Decreased insulin levels in the cerebrospinal fluid (CSF) of AD patients, likely due to peripheral hyperinsulinemia and reduced transport across the blood–brain barrier (BBB), further complicate this relationship [13]. This evidence concerns the gene INS and Alzheimer disease.